Revolution Medicines Inc [RVMD] stock is trading at $45.29, up 2.03%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RVMD shares have gain 5.40% over the last week, with a monthly amount drifted -21.23%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 16, 2024, when Needham reiterated its Buy rating and also boosted its price target to $62 from $46. Previously, Barclays started tracking the stock with Overweight rating on July 12, 2024, and set its price target to $52. On July 08, 2024, Jefferies initiated with a Buy rating and assigned a price target of $63 on the stock. Needham reiterated its Buy rating and increased its price target to $46 on April 12, 2024. Raymond James upgraded its rating to a Strong Buy and raised its price target to $48 on April 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on March 11, 2024, and assigned it a price target of $43. In a note dated January 05, 2024, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $31 to $34.
Revolution Medicines Inc [RVMD] stock has fluctuated between $25.93 and $62.40 over the past year. Currently, Wall Street analysts expect the stock to reach $65.67 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $45.29 at the most recent close of the market. An investor can expect a potential return of 45.0% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
Gross Profit Margin for this corporation currently stands at -179.13% with Operating Profit Margin at -880.32%, Pretax Profit Margin comes in at -763.77%, and Net Profit Margin reading is -764.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.34 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.25 points at the first support level, and at 43.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 45.99, and for the 2nd resistance point, it is at 46.68.
Ratios To Look Out For
For context, Revolution Medicines Inc’s Current Ratio is 14.24. Further, the Quick Ratio stands at 14.24, while the Cash Ratio is 1.82. Considering the valuation of this stock, the price to sales ratio is 11160.30, the price to book ratio is 4.85.
Transactions by insiders
Recent insider trading involved Horn Margaret A, Chief Operating Officer, that happened on Dec 16 ’24 when 4329.0 shares were sold., GOLDSMITH MARK A completed a deal on Dec 16 ’24 to sell 11714.0 shares. Meanwhile, Kelsey Stephen Michael sold 4663.0 shares on Dec 16 ’24.
